Cargando…

Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy

BACKGROUND: Combined, platinum-based thoracic chemoradiotherapy (TCR) is the current state-of-the-art treatment for patients with limited disease (LD) small-cell lung cancer (SCLC). There is only limited data available regarding the effect of comorbidities on survival following TRC. The purpose of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fink, Christoph A., Weykamp, Fabian, Adeberg, Sebastian, Bozorgmehr, Farastuk, Christopoulos, Petros, Lang, Kristin, König, Laila, Hörner-Rieber, Juliane, Thomas, Michael, Steins, Martin, El-Shafie, Rami A., Rieken, Stefan, Bernhardt, Denise, Debus, Jürgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410177/ https://www.ncbi.nlm.nih.gov/pubmed/37564923 http://dx.doi.org/10.1016/j.ctro.2023.100665

Ejemplares similares

Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy
por: Bernhardt, Denise, et al.
Publicado: (2018)

Consolidation Immunotherapy After Platinum-Based Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer—Cross-Sectional Study of Eligibility and Administration Rates
por: Eichkorn, Tanja, et al.
Publicado: (2020)

High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes
por: Eichkorn, Tanja, et al.
Publicado: (2023)

Paclitaxel for treatment of advanced small cell lung cancer (SCLC): a retrospective study of 185 patients
por: von Eiff, Damian, et al.
Publicado: (2020)

Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
por: Eichkorn, Tanja, et al.
Publicado: (2021)

Adjuvant Radiation Therapy for Male Breast Cancer—A Rare Indication?
por: Forster, Tobias, et al.
Publicado: (2020)

Progression of Pulmonary Function and Correlation with Survival Following Stereotactic Body Radiotherapy of Central and Ultracentral Lung Tumors
por: Regnery, Sebastian, et al.
Publicado: (2020)

Parenchymal and Functional Lung Changes after Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer—Experiences from a Single Institution
por: Hörner-Rieber, Juliane, et al.
Publicado: (2017)

Bimodality treatment of patients with pelvic adenoid cystic carcinoma with photon intensity-modulated radiotherapy plus carbon ion boost: a case series
por: Bernhardt, Denise, et al.
Publicado: (2018)

Analysis of the Impact of Comorbidities on Endometrial Lesions Using the Charlson Comorbidity Index in Western Romania
por: Furau, Alexandru, et al.
Publicado: (2021)

An electronic application for rapidly calculating Charlson comorbidity score
por: Hall, William H, et al.
Publicado: (2004)

Palliative Radiotherapy for Leptomeningeal Carcinomatosis–Analysis of Outcome, Prognostic Factors, and Symptom Response
por: El Shafie, Rami A., et al.
Publicado: (2019)

Metformin Enhanced in Vitro Radiosensitivity Associates with G2/M Cell Cycle Arrest and Elevated Adenosine-5’-monophosphate-activated Protein Kinase Levels in Glioblastoma
por: Adeberg, Sebastian, et al.
Publicado: (2017)

Outcome after Radiotherapy for Vestibular Schwannomas (VS)—Differences in Tumor Control, Symptoms and Quality of Life after Radiotherapy with Photon versus Proton Therapy
por: Küchler, Maike, et al.
Publicado: (2022)

Whole brain radiation therapy alone versus radiosurgery for patients with 1–10 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized controlled trial
por: Bernhardt, Denise, et al.
Publicado: (2018)

The Relationship between Post-COVID Syndrome and the Burden of Comorbidities Assessed Using the Charlson Comorbidity Index
por: Falsetti, Lorenzo, et al.
Publicado: (2023)

Comparison of the Freiburg and Charlson Comorbidity Indices in Predicting Overall Survival in Elderly Patients with Newly Diagnosed Multiple Myeloma
por: Kim, Sung Min, et al.
Publicado: (2014)

Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis
por: El Shafie, Rami A, et al.
Publicado: (2019)

Do Increased Doses to Stem-Cell Niches during Radiation Therapy Improve Glioblastoma Survival?
por: Adeberg, Sebastian, et al.
Publicado: (2016)

Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden
por: Ludvigsson, Jonas F, et al.
Publicado: (2021)

Validation of Nine Different Prognostic Grading Indexes for Radiosurgery of Brain Metastases in Breast Cancer Patients and Development of an All-Encompassing Prognostic Tool
por: Weykamp, Fabian, et al.
Publicado: (2020)

Recalibration and Validation of the Charlson Comorbidity Index in Korean Incident Hemodialysis Patients
por: Park, Jae Yoon, et al.
Publicado: (2015)

Charlson comorbidity index as a predictor of periodontal disease in elderly participants
por: Lee, Jae-Hong, et al.
Publicado: (2018)

Developing an adapted Charlson comorbidity index for ischemic stroke outcome studies
por: Hall, Ruth E., et al.
Publicado: (2019)

National Norms for the Elixhauser and Charlson Comorbidity Indexes Among Hospitalized Adults
por: Loyd, Christine, et al.
Publicado: (2021)

The prognostic value of the Charlson comorbidity index in aged patients with intracerebral hemorrhage
por: Zhang, Tianjie, et al.
Publicado: (2022)

Charlson comorbidity index applied to shunted idiopathic normal pressure hydrocephalus
por: Klinge, Petra M., et al.
Publicado: (2023)

Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden [Corrigendum]
Publicado: (2023)

The Ability of Comorbidity Indices to Predict Mortality After Heart Transplantation: A Validation of the Danish Comorbidity Index for Acute Myocardial Infarction, Charlson Comorbidity Index, and Elixhauser Comorbidity Index
por: Bonnesen, Kasper, et al.
Publicado: (2023)

Cone-Beam-CT Guided Adaptive Radiotherapy for Locally Advanced Non-small Cell Lung Cancer Enables Quality Assurance and Superior Sparing of Healthy Lung
por: Hoegen, Philipp, et al.
Publicado: (2020)

Age-adjusted Charlson comorbidity score is associated with the risk of empyema in patients with COPD
por: Ho, Chung-Han, et al.
Publicado: (2017)

Age-adjusted charlson comorbidity index and 30-day morbidity in pelvic surgeries
por: Dessai, Sampada B., et al.
Publicado: (2018)

The relationship of Charlson comorbidity index with stent restenosis and extent of coronary artery disease
por: Karabağ, Turgut, et al.
Publicado: (2018)

The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients
por: Zhou, Shi, et al.
Publicado: (2022)

Charlson Comorbidity Index as a Predictor of Difficult Cholecystectomy in Patients With Acute Cholecystitis
por: Alburakan, Ahmed A, et al.
Publicado: (2022)

Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial
por: Bozorgmehr, Farastuk, et al.
Publicado: (2020)

Correction: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial
por: Bozorgmehr, Farastuk, et al.
Publicado: (2023)

Effectiveness and Toxicity of Fractionated Proton Beam Radiotherapy for Cranial Nerve Schwannoma Unsuitable for Stereotactic Radiosurgery
por: Eichkorn, Tanja, et al.
Publicado: (2021)

Effect of Comorbidity Assessed by the Charlson Comorbidity Index on the Length of Stay, Costs and Mortality among Older Adults Hospitalised for Acute Stroke
por: Ofori-Asenso, Richard, et al.
Publicado: (2018)

Comorbidity and thirty-day hospital readmission odds in chronic obstructive pulmonary disease: a comparison of the Charlson and Elixhauser comorbidity indices
por: Buhr, Russell G., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oi9e0t0okalk19oranra3pjuuv